PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Japan.\', \'Department of Complex Systems Science, Graduate School of Informatics, Nagoya University, Japan.\', \'Computational Biology Laboratory Division of Information Science, Graduate School of Science and Technology, Nara Institute of Science and Technology (NAIST), Ikoma, Japan.\', \'Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Japan.\', \'Transborder Medical Research Center, University of Tsukuba, Japan.\', \'Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tokyo, Japan.\', \'Department of Virology II, National Institute of Infectious Diseases, Shinjuku-ku, Japan.\', \'Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Shinjuku-ku, Japan.\', \'Department of Applied Biological Sciences, Tokyo University of Science, Noda, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/2211-5463.13337
?:hasPublicationType
?:journal
  • FEBS open bio
is ?:pmid of
?:pmid
?:pmid
  • 34850606
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.884
?:rankingScore_hIndex
  • 21
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all